Neurodegenerative Diseases Drugs Market Expected to Transform with Novel Drug Approvals
The neurodegenerative diseases drugs market is on a strong growth trajectory, driven by rising prevalence of neurological disorders, advancements in pharmaceutical research, and increasing healthcare awareness globally. Valued at approximately US$ 58.4 billion in 2025, the market is projected to reach US$ 85.0 billion by 2032, growing at a compound annual growth rate (CAGR) of 5.5% during the forecast period from 2025 to 2032. This report provides a comprehensive analysis of the market dynamics, segmentation, regional insights, key players, and emerging trends shaping the future of neurodegenerative disease therapeutics.